Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
  1. 4 Planned sale General Counsel sold 1,799 shares at $44.26 ($79,624)
  2. 4 Planned sale Chief Medical Officer sold 2,160 shares at $45.82 ($98,982)
  3. 4 Planned sale Kelsey Stephen Michael sold 5,367 shares at $45.82 ($245,942)
  4. 4 Planned sale GOLDSMITH MARK A sold 13,411 shares at $45.82 ($614,558)
  5. 4 Planned sale Chief Operating Officer sold 4,775 shares at $45.82 ($218,814)
  6. 4 Planned sale General Counsel sold 1,869 shares at $45.82 ($85,647)
  7. 4 Planned sale Chief Financial Officer sold 2,320 shares at $45.82 ($106,314)
  8. 4 Planned sale Kelsey Stephen Michael sold 125,000 shares at an average $44.46 ($5,557,754)
  9. 4 Planned sale Chief Financial Officer sold 10,000 shares at an average $40.10 ($400,992)
  10. 4 Exercise or conversion GOLDSMITH MARK A acquired 37,000 shares (option exercise)
  11. 4 Grant or award Director acquired 3,142 shares (grant or award)
  12. 4 Grant or award Director acquired 3,142 shares (grant or award)
  13. 4 Grant or award Director acquired 3,142 shares (grant or award)
  14. 4 Grant or award Director acquired 3,142 shares (grant or award)
  15. 4 Grant or award Director acquired 3,142 shares (grant or award)
  16. 4 Grant or award Director acquired 3,142 shares (grant or award)
  17. 4 Grant or award Director acquired 2,806 shares (grant or award)
  18. 4 Planned sale General Counsel sold 1,912 shares at $39.61 ($75,736)
  19. 4 Planned sale Chief Operating Officer sold 3,510 shares at $39.83 ($139,803)
  20. 4 Planned sale GOLDSMITH MARK A sold 13,496 shares at $39.83 ($537,546)

Page 5 of 21 · 414 filings